28
total announcements
544476.BO · 15 min delayed
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the launch of six new products under its Ayurvedic, healthcare and wellness product portfolio, including Narie Xpert Granules 80g, Narie Xpert Syrup 500 Ml, Narie Xpert Tablet 52 Tab, Porush Xpert Granules 80g, Porush Xpert Syrup 500 Ml, and Porush Xpert Tablet 52 Tab. The products are expected to be launched on 02nd September 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has fixed the date of its 9th Annual General Meeting (AGM) for September 28, 2026, and has recommended a final dividend of ₹4.50 per equity share for the FY 2025-26. The Board has also appointed a Scrutinizer to oversee the remote e-voting process and the voting process at the AGM.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has fixed Monday, 21st September, 2026 as the Record date for Dividend, if declared. The company has also announced the 9th Annual General Meeting (AGM) on Monday, September 28, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has fixed Monday, 21st September, 2026 as the Record Date for determining the eligibility of members entitled to receive the final dividend, if declared at the 9th AGM.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd announced the outcome of its Board meeting, where it approved the Annual Report for FY 2025-26, fixed the date for the 9th AGM, and declared a final dividend of ₹4.50 per equity share. The company also fixed the book closure period from September 22 to 28, 2026, and the record date for the final dividend as September 21, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the outcome of its board meeting, where it approved the annual report for FY 2025-26, fixed the date of the 9th AGM, and declared a final dividend of ₹4.50 per equity share. The record date for the final dividend has been fixed as Monday, 21st September, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has informed about an analyst/investor meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, scheduled to be held on 3rd September 2026 at Grand Hyatt, Santacruz, Mumbai.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the launch of 9 new Ayurvedic products, including Headache Relief Patch and various Arishta products, as part of its existing product portfolio. The company has disclosed the details of the new products in accordance with SEBI regulations.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has scheduled an analyst/investor meet on 31st August 2026 to discuss the company's performance with investors and analysts at GIA Healthcare Day.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced its Q1 FY27 results, with revenue from operations growing 29% YoY to ₹224.4 crore, driven by private-pay Panchakarma hospitalisation, at-centre medicine sales, and digital/e-commerce medicine channel. The company has also provided an update on its IPD growth, business mix, and operating performance.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has published case studies in the 'Academia Journal of Medicine and Prakriti - The International Multidisciplinary Research Journal' to demonstrate its commitment to Ayurvedic research and evidence-based clinical practice.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has published case studies on Ayurvedic research and clinical practice in two international journals.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has submitted the transcript of its Earnings Conference Call for Q1 FY27, which ended on June 30, 2026, on its website.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced a proposal to establish a new Ayurvedic, Naturopathy and Panchkarma Hospital facility at Bareilly, Uttar Pradesh, as part of its expansion strategy. The proposed hospital unit will have an estimated capacity of 40+ beds and is expected to commence operations in November 2026. The company will utilize internal finance (owned funds) to fund the investment of approximately ₹85 Lakh.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has submitted the audio recording of its Earnings Conference Call for Q1 FY 2026-27, which can be accessed on the company's website.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has submitted an investor presentation to the exchange, detailing its quarterly performance and growth prospects.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has submitted the newspaper advertisement clipping of its unaudited financial results for the quarter ended June 30, 2026, as per SEBI regulations.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the reappointment of Mr. Karan Vir Bindra as Independent Director, Mrs. Bhavna Grover as Whole-time Director, and Mr. Manish Grover as Managing Director, subject to shareholder approval.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the outcome of its board meeting held on August 07, 2026, where the board approved the re-appointment of three directors, including Mr. Karan Vir Bindra, Mrs. Bhavna Grover, and Mr. Manish Grover, subject to shareholder approval.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the approval of unaudited financial results for the quarter ended June 30, 2026, along with the re-appointment of three directors, including Mr. Karan Vir Bindra, Mrs. Bhavna Grover, and Mr. Manish Grover, subject to shareholder approval.